Patent US5467767A successfully refreshed from Google Patents.
US5467767A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method for determining if tissue is malignant as opposed to non-malignant using time-resolved fluorescence spectroscopy
Assignee: Individual
•
Filing: 1993-08-27
•
Granted: 1995-11-21
•
Expires: 2013-08-27
Abstract
Abstract A method for determining if tissue is malignant as opposed to non-malignant (i.e., benign tumor tissue, benign tissue, or normal tissue). In one embodiment, the method comprises irradiating a human breast tissue sample with light at a wavelength of about 310 nm and measuring the time-resolved fluorescence emitted therefrom at about 340 nm. The time-resolved fluorescence profile is then compared to similar profiles obtained from known malignant and non-malignant human breast tissues. By fitting the profiles to the formula I(t)=A 1 e.sup.(-t/τ 1.sup.) +A 2 e.sup.(-t/τ 2.sup.), one can quantify the differences between tissues of various conditions. For example, non-malignant human breast tissues exhibit a slow component (τ 2 ) which is less than 1.6 ns whereas malignant human breast tissues exhibit a slow component (τ 2 ) which is greater than 1.6 ns. In addition, non-malignant human breast tissues exhibit a ratio of fast to slow amplitudes (A 1 /A 2 ) which is greater than 0.85 whereas malignant human breast tissues exhibit a ratio of fast to slow amplitudes (A 1 /A 2 ) which is less than 0.6. This technique can be used with different excitation and/or emission wavelengths, and can be applied to the detection of malignancies (or other abnormal states) in tissues other than human breast tissue.
Inventors
- 👤 Robert R. Alfano
- 👤 Asima Pradhan
- 👤 Guichen C. Tang
- 👤 Leming Wang
- 👤 Yury Budansky
- 👤 Bidyut B. Das
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 12:17
CPC Classifications
G; G01; G01N; G01N21/00; G01N21/62; G01N21/63; G01N21/64; G01N21/6408; A; A61; A61B; A61B1/00; A61B1/04; A61B1/043; A61B5/00; A61B5/0059; A61B5/0071; A61B5/0082; A61B5/0084; A61B5/0091; A61B5/43; A61B5/4306; A61B5/4312; B; B23; B23K; B23K26/00; B23K26/02; B23K26/06; B23K26/062; B23K26/0622; B23K26/0624; G01N21/6486; A61B5/0075; A61B5/0086; G01N2021/6417
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
110 words
A method for determining if a human breast tissue sample is malignant as opposed to non-malignant comprising: a) irradiating the human breast tissue sample with light at a wavelength of about 310 nm whereby native time-resolved fluorescence is emitted therefrom; b) measuring the native time-resolved fluorescence emitted therefrom at a wavelength of about 340 nm; and c) comparing the native time-resolved fluorescence emitted from the human breast tissue sample to that emitted from known malignant and non-malignant human breast tissues; d) the irradiating and measuring steps being performed using a fiber optic bundle in combination with a hypodermic needle to convey the light to and from the human breast tissue.
Claim 2
Independent Claim
110 words
A method for determining if a human breast tissue sample is malignant as opposed to non-malignant comprising: a) irradiating the human breast tissue sample with light at a wavelength of about 310 nm whereby native time-resolved fluorescence is emitted therefrom; b) measuring the native time-resolved fluorescence emitted therefrom at a wavelength of about 340 nm; and c) comparing the native time-resolved fluorescence emitted from the human breast tissue sample to that emitted from known malignant and non-malignant human breast tissues; d) the irradiating and measuring steps being performed using a fiber optic bundle in combination with a hypodermic needle to convey the light to and from the human breast tissue.
Claim 3
Dependent Claim
49 words
The method as claimed in claim 1 wherein said measuring step is performed with a measuring device selected from the group consisting of a streak camera, an optical Kerr gate, an up-conversion gate, a time-correlated single photon counting instrument, a phase fluorimeter, and an oscilloscope with a fast photodetector.
Claim 4
Dependent Claim
17 words
The method as claimed in claim 1 wherein said measuring step is performed with a streak camera.
Claim 5
Independent Claim
110 words
A method for determining if a tissue sample selected from the group consisting of human breast tissue and human ovarian tissue is malignant as opposed to non-malignant comprising: a) irradiating the tissue sample with light at a wavelength of about 353 nm; b) measuring a native time-resolved fluorescence emitted therefrom over one or more wavelengths in a spectral band from about 400 nm to about 500 nm; and c) determining the condition of the tissue sample in accordance with said measurement; d) the irradiating and measuring steps being performed using a fiber optic bundle in combination with a hypodermic needle to convey the light to and from the tissue sample.
Claim 6
Independent Claim
110 words
A method for determining if a tissue sample selected from the group consisting of human breast tissue and human ovarian tissue is malignant as opposed to non-malignant comprising: a) irradiating the tissue sample with light at a wavelength of about 353 nm; b) measuring a native time-resolved fluorescence emitted therefrom over one or more wavelengths in a spectral band from about 400 nm to about 500 nm; and c) determining the condition of the tissue sample in accordance with said measurement; d) the irradiating and measuring steps being performed using a fiber optic bundle in combination with a hypodermic needle to convey the light to and from the tissue sample.
Claim 7
Independent Claim
110 words
A method for determining if a tissue sample selected from the group consisting of human breast tissue and human lung tissue is malignant as opposed to non-malignant comprising: a) irradiating the tissue sample with light at a wavelength of about 530 nm; b) measuring a native time-resolved fluorescence emitted therefrom over one or more wavelengths in a spectral band from about 500 nm to about 600 nm; and c) determining the condition of the tissue sample in accordance with said measurement; d) the irradiating and measuring steps being performed using a fiber optic bundle in combination with a hypodermic needle to convey the light to and from the tissue sample.
Claim 8
Independent Claim
110 words
A method for determining if a tissue sample selected from the group consisting of human breast tissue and human lung tissue is malignant as opposed to non-malignant comprising: a) irradiating the tissue sample with light at a wavelength of about 530 nm; b) measuring a native time-resolved fluorescence emitted therefrom over one or more wavelengths in a spectral band from about 500 nm to about 600 nm; and c) determining the condition of the tissue sample in accordance with said measurement; d) the irradiating and measuring steps being performed using a fiber optic bundle in combination with a hypodermic needle to convey the light to and from the tissue sample.
References Cited (Backward Citations)
US3961621A
Cited
US3941121A
Cited
US4311138A
Cited
US4410020A
Cited
JPS58222331A
Cited
US4532935A
Cited
US4502487A
Cited
US4622974A
Cited
US4566438A
Cited
US4957114A
Cited
US4930516A
Cited
US5042494A
Cited
US4930516B1
Cited
US5131398A
Cited
US5280788A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1998-11-20 | 1999-05-22 | 1999-11-21 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2002-11-20 | 2003-05-22 | 2003-11-21 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2006-11-20 | 2007-05-22 | 2007-11-21 | $7700.00 | Window Closed / Lapsed |